# BridgeBio Pharma, Inc.: Form 8-K, filed Oct 11, 2019

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 8-K
- Filed: 2019-10-11
- Accepted by EDGAR: Oct 11, 2019, 17:02 ET
- Period: 2019-10-07
- Accession: 0001193125-19-266824
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312519266824/d811702d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312519266824/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312519266824/d811702d8k.htm

Filed Oct 11, 2019.
Source: SEC EDGAR, the filing index for accession 0001193125-19-266824. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
